Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of propofol injectable emulsion (containing benzyl alcohol), 100 mL single-patient use glass fliptop vial; lot EA7470, to the user level due to visible particulates observed in two vials during an annual examination of retention samples.
Patients receiving the affected product have a remote probability for potential adverse events, such as blockage of blood vessels, including decreased blood flow to the brain, heart attack,